How is swine flu (H1N1) diagnosed?
January 9, 2010 by MedicineNewsReporter · 1 Comment
Swine flu is presumptively diagnosed clinically by the patient’s history of association with people known to have the disease and their symptoms listed above. Usually, a quick test (for example, nasopharyngeal swab sample) is done to see if the patient is infected with influenza A or B virus. Most of the tests can distinguish between A and B types. The test can be negative (no flu infection) or positive for type A and B. If the test is positive for type B, the flu is not likely to be swine flu (H1N1). If it is positive for type A, the person could have a conventional flu strain or swine flu (H1N1). However, the accuracy of these tests has been challenged, and the U.S. Centers for Disease Control and Prevention (CDC) has not completed their comparative studies of these tests. However, a new test developed by the CDC and a commercial company reportedly can detect H1N1 reliably in about one hour; as of October 2009, the test is only available to the military.
Swine flu (H1N1) is definitively diagnosed by identifying the particular antigens associated with the virus type. In general, this test is done in a specialized laboratory and is not done by many doctors’ offices or hospital laboratories. However, doctors’ offices are able to send specimens to specialized laboratories if necessary. Because of the large number of novel H1N1 swine flu cases (as of October 2009, the vast majority of flu cases [about 99%] are due to novel H1N1 flu viruses), the CDC recommends only hospitalized patients’ flu virus strains be sent to reference labs to be identified.
Ginseng is nature’s anti-inflammatory
December 18, 2009 by MedicineNewsReporter · Leave a Comment
CM NEWS – The famous immunological effects of ginseng have been confirmed and defined by a recent study. Ginseng is believed to have beneficial effects against human diseases, and its active components, ginsenosides, may play critical roles in its diverse physiological actions.
Researchers writing in BioMed Central’s open access Journal of Translational Medicine have shown that the herb, much used in traditional Chinese and other Asian medicine, does have anti-inflammatory effects.
What are the powers of ginseng? Ginseng roots contain multiple active constituents including ginsenosides, polysaccharides, peptides, polyacetylenic alcohols and fatty acids that have been shown to have different effects on carbohydrate and lipid metabolism as well as on the function of neuroendocrine, immune, cardiovascular and central nervous systems in humans.
Previous studies have shown that ginseng and its active components are potent immunomodulators. Their immunomodulatory effects are mostly due to its regulation of cytokine production and phagocytic activities of monocytes/macrophages and dendritic cells, as well as activation of T- and B- lymphocytes.
Ginsenosides, the steroid saponins, are major biologically active compounds of ginseng. Over 30 ginsenosides have been identified to date. Studies indicate that ginsenosides and their metabolites are responsible for many of the diverse physiological actions including the anti-inflammatory effects of ginseng.

Allan Lau led a team of researchers from the University of Hong Kong who identified seven ginseng constituents, ginsenosides, which showed immune-suppressive effects.
He said, “The anti-inflammatory role of ginseng may be due to the combined effects of these ginsenosides, targeting different levels of immunological activity, and so contributing to the diverse actions of ginseng in humans”.
The scientists treated human immune cells with different extracts of ginseng. They found that of the nine ginsenosides they identified, seven could selectively inhibit expression of the inflammatory gene CXCL-10.
Lau concludes, “Further studies will be needed to examine the potential beneficial effects of ginsenosides in the management of acute and chronic inflammatory diseases in humans”.
Uniquely, the researchers were able to holistically test the ginseng extract’s immune effects by using sophisticated purification technologies to identify individual constituents and define their bioactivity using genomics and bioactivity assays. After that, they reconstituted them back into a whole extract with definable individual ginsenosides for re-confirmation of effects. This potentially opens up a vigorous methodology to study medicinal herbs with state-of-the-art technologies.
Single-stranded DNA-binding protein is dynamic, critical to DNA repair
October 22, 2009 by MedicineNewsReporter · Leave a Comment
CHAMPAIGN, Ill. Researchers report that a single-stranded DNA-binding protein (SSB), once thought to be a static player among the many molecules that interact with DNA, actually moves back and forth along single-stranded DNA, gradually allowing other proteins to repair, recombine or replicate the strands.
Their study, of SSB in the bacterium Escherichia coli, appears today in the journal Nature.
Whenever the double helix of DNA unravels, exposing each strand to the harsh environment of the cell, SSB is usually first on the scene, said University of Illinois physics professor and Howard Hughes Medical Institute investigator Taekjip Ha, who led the study.
Although DNA unwinding is necessary for replication or recombination, it is normally a transient process, he said. Exposed single-stranded DNA (ssDNA) can be damaged or degraded by enzymes in the cell. Damaged DNA may also come unwound, and ssDNA can bond to itself, forming hairpin loops and other problematic structures.
“If you have lots of single-stranded DNA in the cell, basically it’s a sign of trouble,” Ha said. “SSB needs to come and bind to it to protect it from degradation and to control what kind of proteins have access to the single-stranded DNA.”
Although other proteins are known to travel along double-stranded DNA, this is the first study to find a protein that migrates back and forth randomly on single-stranded DNA, Ha said.
Other researchers had assumed that SSB simply bound to DNA where it was needed and then fell off when its job was done. But a collaborator on the new study who has studied SSB for two decades, Timothy Lohman, of Washington University School of Medicine, suspected that the protein’s interaction with DNA was more dynamic. That hunch turned out to be true, Ha said.
The SSB protein is made up of four identical subunits. Single-stranded DNA loops around and through them in a pattern “that looks like the s
Pityriasis Rosea
September 12, 2009 by MedicineNewsReporter · Leave a Comment
What is pityriasis rosea?
Pityriasis rosea is a common rash usually seen in individuals between the ages of 10 to 35 years old. The rash typically lasts six to eight weeks, rarely extending 12 weeks or longer. Once a person has pityriasis rosea, it generally does not recur in their lifetime.
Pityriasis rosea characteristically begins as an asymptomatic single, large pink patch called the “herald patch” or mother patch, measuring 2-10 centimeters. The herald patch is a dry, pink to red patch which appears on the back, chest, or neck and has a well-defined, scaly border.
One to two weeks following the initial appearance of the herald patch, a person will then develop many smaller pink patches across their trunk, arms, and legs. The second stage of pityriasis rosea erupts with a large number of oval spots, ranging in diameter from 0.5 centimeter (size of a pencil eraser) to 1.5 centimeters (size of a peanut). The individual spots form a symmetrical “Christmas tree” pattern following lines of cleavage. This rash is usually limited to the trunk, arms, and legs, rarely occurring on the face and neck. Pityriasis rosea generally spares the face, hands, and feet.
Who gets pityriasis rosea?
Pityriasis rosea is, for the most part, equally common between the two sexes, although there is a slightly higher occurrence reported in women. It generally occurs in children and young adults between 10-35 years of age. Pityriasis rosea has no racial predominance. Most people only get pityriasis once in their lifetime, although it is theoretically possible to have it more than once.
What are signs and symptoms of pityriasis rosea?
Most people do not notice any symptoms with pityriasis rosea except for the appearance of the rash itself. Mild, intermittent itching is reported in about 50% of individuals affected, especially when people become overheated from exercise or hot showers. Itching seems to increase with stress. Sometimes pityriasis is accompanied by flu-like symptoms, such as sore throat, fatigue, nausea, aching, and decreased appetite. Most people are otherwise in very good health and don’t feel any other symptoms.



